Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to...

Area of Science:

• Oncology
• Pathology
• Biomarker Detection

Background:

• Human epidermal growth factor receptor type 2 (HER2) amplification and overexpression are key targets for cancer therapies, including in breast, gastric, and colorectal cancers.
• Accurate HER2 status determination is critical for guiding treatment decisions in patients with HER2-positive cancers.
• Current methods for HER2 detection require standardization to ensure consistent and reliable results in clinical practice.

Purpose of the Study:

• To develop and evaluate tissue microarray (TMA) slides derived from xenografted gastric tumors as standardized control slides for HER2 testing.
• To assess the utility of these TMA slides for standardizing staining conditions and improving the accuracy of HER2 detection using various clinical kits.

Main Methods:

• Preparation of TMA slides using gastric cancer cell lines with varying HER2 expression levels (0, 1+, 2+, 3+).
• Xenografting of these cell lines in NOG mice and subsequent construction of TMA slides from tumor samples.
• Evaluation of staining properties using six different clinical HER2 diagnostic kits on the prepared TMA slides.

Main Results:

• HER2-positive tumors (HER2 scores 3+ and 2+) on TMA slides demonstrated consistent and good staining with all tested diagnostic kits.
• The staining patterns observed in the TMA slides closely resembled those of clinical samples.
• Xenograft-derived TMA slides showed potential as external controls for standardizing HER2 staining.

Conclusions:

• Xenograft tumor-derived TMA slides can serve as effective external controls for standardizing HER2 staining protocols.
• The proposed method has the potential to enhance the accuracy and reliability of HER2 detection in clinical settings.
• Standardized HER2 testing using these control slides can lead to more precise patient stratification for HER2-targeted therapies.